Oligschlaeger Yvonne, Shiri-Sverdlov Ronit
Department of Molecular Genetics, School of Nutrition and Translational Research in Metabolism (NUTRIM), Maastricht University, Universiteitssingel 50, 6229 ER, Maastricht, The Netherlands.
Biomedicines. 2020 Feb 8;8(2):28. doi: 10.3390/biomedicines8020028.
Non-alcoholic fatty liver disease (NAFLD) is a spectrum of liver diseases ranging from simple steatosis to non-alcoholic steatohepatitis, fibrosis, cirrhosis, and/or hepatocellular carcinoma. Due to its increasing prevalence, NAFLD is currently a major public health concern. Although a wide variety of preclinical models have contributed to better understanding the pathophysiology of NAFLD, it is not always obvious which model is best suitable for addressing a specific research question. This review provides insights into currently existing models, mainly focusing on murine models, which is of great importance to aid in the identification of novel therapeutic options for human NAFLD.
非酒精性脂肪性肝病(NAFLD)是一系列肝脏疾病,范围从单纯性脂肪变性到非酒精性脂肪性肝炎、纤维化、肝硬化和/或肝细胞癌。由于其患病率不断上升,NAFLD目前是一个主要的公共卫生问题。尽管各种各样的临床前模型有助于更好地理解NAFLD的病理生理学,但哪种模型最适合解决特定的研究问题并不总是显而易见的。本综述深入探讨了目前现有的模型,主要侧重于小鼠模型,这对于帮助确定人类NAFLD的新治疗选择非常重要。